Similar articles

• Post-exposure prophylaxis for H1N1 with oseltamivir in renal allograft recipient--safe and effective without any immunosuppresive drug interaction.

  Kute V, Goplani KR, Godara SM, Shah PR, Vanikar AV, Trivedii HL. Kute V, et al. J Assoc Physicians India. 2011 Jan;59:49-51. J Assoc Physicians India. 2011. PMID: 21751666
• Fatal oseltamivir-resistant influenza virus infection.

  van der Vries E, van den Berg B, Schutten M. van der Vries E, et al. N Engl J Med. 2008 Sep 4;359(10):1074-6. doi: 10.1056/NEJMc0803120. N Engl J Med. 2008. PMID: 18768958 No abstract available.
• Postexposure prophylaxis of H1N1 with oseltamivir in a newly transplanted kidney recipient receiving intense immunosuppressive therapy.

  Marfo K, Chapochnick-Friedmann J, Akalin E, Lu A. Marfo K, et al. Transplant Proc. 2009 Dec;41(10):4411-3. doi: 10.1016/j.transproceed.2009.09.052. Transplant Proc. 2009. PMID: 20005410
• More resistance to oseltamivir (Tamiflu).

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2009 Jan 26;51(1304):5-6. Med Lett Drugs Ther. 2009. PMID: 19172138 Review. No abstract available.
• Update on 2009 pandemic influenza A (H1N1) virus.

  Gordon SM. Gordon SM. Cleve Clin J Med. 2009 Oct;76(10):577-82. doi: 10.3949/ccjm.76a.05009. Cleve Clin J Med. 2009. PMID: 19797457 Review.